A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Omada Health OMDA

Promising (early) broader-coverage candidate · Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskele

On FrontierLab's discovery record since 2026-07-02 (7 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Promising (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-11), not the curated Frontier signal.

⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)	47.6%
Gross margin	68.2%
Gross profits / assets	0.64
Rule of 40	47.5
Net margin	-0.1%
Cash runway (months)	—
PEG	—
Price / sales	4.8

Quality checklist

✓ Revenue growth — 47.6% (pass ≥ 20%)
✓ Capital efficiency
✓ Gross margin — 68.2% (pass ≥ 60%)
✓ Gross-margin trend — 5.1 (pass ≥ 2)
~ Share dilution — 11.6%

Fundamentals — snapshot as of 2026-08-11

Stage	Early
Share issuance (YoY)	11.6% · heavy issuance
Moat	—
TAM	—
P/E (trailing)	396.7
EPS (trailing)	$0.06
Burn multiple	—
Gross-margin trend (pts)	5.1
Cash / assets	0.68
Net debt / EBITDA	-18.9
Statements as of	Q2 FY2026 · filed 2026-08-07

Momentum context — a snapshot from 2026-08-11, not current

Price at surface	$24.99 (as of 2026-08-11)
52-week range	$10.28 – $26.915
% off 52-wk high	-7.2%
RSI (14)	69
Relative volume	1.7×

Risk flags

Burning cash — operating margin is negative.Heavy dilution (~12%/yr) — top-decile share issuers have historically underperformed.IPO'd under 18 months ago and not yet self-funding at scale — young issuers like this have the worst base rates.Parabolic one-day spike (+21%) in the last month — extreme single-day moves tend to mean-revert.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-08-11 (end-of-day). How grades are computed →